ALNY
ALNYLAM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$239.56
−2.42%Forward multiples
Based on analyst estimates
- P/E forward
- 28.43x
- P/E 2026E
- 36.26x
- P/E 2027E
- 24.01x
- P/E 2028E
- 19.34x
- P/S forward
- 5.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.27x
- PEG TTM
- 1.04x
- Price / book
- 23.67x
- Price / sales
- 6.67x
- Price / cash flow
- 50.52x
Enterprise value
- Enterprise value
- $30.0B
- EV / sales
- 6.25x
- EV / EBITDA
- 26.09x
- EV / EBIT
- 30.02x
- Market cap
- $32.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026